Gem Aromatics is an established manufacturer of specialty ingredients, including, essential oils and aroma chemicals. Their track record, diverse product portfolio and brand recall has helped them establish several leadership positions within their product portfolio With a commitment. The company believe that their enduring customer relationships serve as a clear testament to their commitment to quality, continuing focus on sustainability, ensure customer satisfaction, product innovation and expertise to deliver essential oils, aromatic chemicals to their domestic and global customers.

Gem Aromatics, an Book Built Issue, amounting to ₹ 451.25 Crores, consisting an Fresh Issue of 0.53 Crore Shares worth ₹ 175.00 Crores and an Offer for Sale of 0.85 Crore Shares totaling to ₹ 276.25 Crores. The subscription period for the Gem Aromatics IPO opens on August 19, 2025, and closes on August 21, 2025. The allotment is expected to be finalized on or about Friday, August 22, 2025, and the shares will be listed on the BSE & NSE with a tentative listing date set on or about Tuesday, August 26, 2025.

The Share Price Band of Gem Aromatics IPO is set at ₹ 309 to ₹ 325 per equity share. The Market Capitalisation of the Gem Aromatics at IPO price of ₹ 325 per equity share will be ₹ 1,697.70 Crores. The lot size of the IPO is 46 shares. Retail investors are required to invest a minimum of ₹ 14,950 (46 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (644 shares), amounting to ₹ 2,09,300.

Motilal Oswal Investment Advisors Limited is the book running lead manager of the Gem Aromatics, while KFin Technologies Limited is the registrar for the issue. 

Gem Aromatics Limited IPO GMP Today
The Grey Market Premium of Gem Aromatics IPO is expected to be ₹ 33 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Gem Aromatics Limited IPO Live Subscription Status Today: Real-Time Update
As of 07:00 PM on 21 August, 2025, the Gem Aromatics Limited IPO live subscription status shows that the IPO subscribed 13.99 times on its Final Day of subscription period. Check the Gem Aromatics IPO Live Subscription Status Today at BSE.

Gem Aromatics IPO Anchor Investors Report
Gem Aromatics has raised ₹ 135.37 Crores from Anchor Investors at a price of ₹ 325 per shares in consultation of the Book Running Lead Managers. The company allocated 41,65,383 equity shares to the Anchor Investors. Check Full List of Gem Aromatics Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion.

Gem Aromatics Limited Day Wise IPO GMP Trend

Date	IPO Price	Expected Listing Price	GMP	Last Updated
14 August 2025	₹ 325	₹ 358	₹ 33 (10.15%)	12:00 PM; 14 August 2025

Gem Aromatics Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Gem Aromatics IPO allotment date is 22 August, 2025, Friday. Gem Aromatics IPO Allotment will be out on 22nd August, 2025 and will be live on Registrar Website from the allotment date. Check Gem Aromatics IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Gem Aromatics Limited IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Gem Aromatics Limited IPO
Gem Aromatics to utilise the Net Proceeds towards the following objects: 
1. ₹ 1,400.00 Million is required for Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and our Subsidiary, Krystal Ingredients Private Limited; and
2. General corporate purposes

Refer to Gem Aromatics Limited RHP for more details about the Company.

Check latest IPO Review & analysis, Live IPO GMP today, Live IPO Subscription Status Today, Share Price, Financial Information and other details before applying in the IPO.

The Upcoming IPOs in this week and coming weeks are Mangal Electrical Industries, LGT Business Connextions, Vikram Solar, Gem Aromatics, Studio LSD, Shreeji Shipping Global, Patel Retail.

The Current active IPO are Regaal Resources, Mahendra Realtors and Infrastructure.

The Closed IPOs are Bluestone Jewellery and Lifestyle, Icodex Publishing Solutions, Star Imaging and Path Lab, Medistep Healthcare, ANB Metal Cast.

The Recently Listed IPOs which is available for trading in stock Market are ConnPlex Cinemas, ALL Time Plastics, JSW Cement, Sawaliya Foods Products, Highway Infrastructure, Parth Electricals & Engineering, Jyoti Global Plast, Essex Marine, Aaradhya Disposal Industries, BLT Logistics, Bhadora Industries, Flysbs Aviation, Cash Ur Drive Marketing, Renol Polychem, B.D. Industries (Pune), NSDL, Takyon Networks, Mehul Colours, M&B Engineering, Sri Lotus Developers & Realty and many more.

Read more

About Gem Aromatics Limited

BUSINESS OVERVIEW

Gem Aromatics is an established Indian manufacturer of specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives, with over two decades of operational track record. The company offers a diversified portfolio ranging from mother ingredients to various value-added derivatives, catering to industries such as oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management, and personal care.

The company is one of the leading essential oil and value-added derivatives manufacturers in India, based on both value and volume, specializing in mint and clove oil-based products. It holds strong market positions in essential oil-based products derived from mint, clove, eucalyptus, and other oils, being present in three of the four largest essential oil categories—orange, mint, clove, and eucalyptus oil.

In FY 2025, the company ranked among India’s largest procurers of piperita oil and leading processors of DMO, clove oil, eugenol, and eucalyptus oil. Market shares stood at 12% for DMO and 65% for eugenol in terms of volume manufactured.

The business operates with in-house manufacturing and R&D capabilities, enabling consistent product innovation, quality, and customisation. Expertise includes advanced organic synthesis using complex chemistries (Grignard’s, amide coupling, Friedel-Crafts, cross-coupling, photochemical reactions, methoxylation via green chemistry), along with capabilities in high-pressure reactions, continuous processes, fixed-bed systems, and automation.

The portfolio spans 70 products across four categories:

1. Mint and mint derivatives

2. Clove and clove derivatives

3. Phenol

4. Other synthetic and natural ingredients

Operations began in 1999 with mint derivatives, expanded into clove derivatives in 2009, and are now adding citral-based products. The company has earned multiple export excellence awards from the Federation of Indian Export Organisation and holds a Three Star Export House status from the Directorate General of Foreign Trade.

In 2019, dōTERRA Enterprises, Sàrl invested in the company. The relationship has expanded from supplying spearmint and piperita to 15 products over the past three fiscals. Long-standing customers include Colgate-Palmolive, Dabur India, Patanjali Ayurved, SH Kelkar, Rossari Biotech, Symrise, dōTERRA, Ventos So Brasil, and Anhui Hautian Spices, along with several domestic and international merchant traders.

In FY 2025, the company served 225 domestic customers and 44 customers across 18 countries, with exports covering the Americas, Asia, Africa, and Australia. Domestic sales are conducted on a B2B basis, while exports occur via direct sales, its U.S. subsidiary Gem Aromatics LLC, or third-party agencies.

Manufacturing operations are spread across three facilities—Budaun (Uttar Pradesh), Silvassa (Dadra and Nagar Haveli and Daman and Diu), and Dahej (Gujarat)—supported by a dedicated R&D facility in Maharashtra with 13 scientists. The R&D team works closely with customers to develop tailor-made formulations matching proprietary ingredient ratios, fragrance profiles, and flavours.

As on March 31, 2025, the company had a workforce of 280 permanent employees and 15 contractual workers. The Bankers to the company are Axis Bank Limited, Citibank N.A., DBS Bank India Limited, HDFC Bank Limited and ICICI Bank Limited.

INDUSTRY ANALYSIS

India Chemical Industry Overview

The Indian chemicals market is valued at USD 235 billion in 2025e, accounting for about 4% of the global chemical industry, with commodity chemicals contributing over 50%. By 2030, the market is projected to touch USD 380 billion, growing at an estimated 10% CAGR. Within this, the specialty chemicals segment accounts for around 40% of the domestic chemical market and is expected to expand at a 10–12% CAGR during 2025–2030, driven by both domestic consumption and exports.

India’s specialty chemical players are increasingly preferred by global multinationals due to the geopolitical realignment post-COVID-19, as industries seek to reduce dependence on China. In 2019, China held 15–17% of global exportable specialty chemicals, while India’s share was only 1–2%. Since the pandemic, India’s share has doubled to 4%, reflecting its growing importance. Specialty chemicals are poised to become the next major export growth driver for the country.

These chemicals find applications in home and personal care, water treatment, construction, and agrochemicals, with demand closely linked to the broader growth of the Indian economy.

India’s Opportunity in Specialty Chemicals

India’s chemical industry is one of the most diversified globally, and the specialty segment is emerging as a significant growth area. Factors such as rising domestic demand, particularly from pharmaceuticals, personal care, and textiles; strong export potential supported by lower labour and production costs; and government-backed schemes like the Production Linked Incentive (PLI) with an outlay of ₹1.97 lakh crore are accelerating this growth.

Technological adoption—digitalization, automation, and green chemistry—is transforming manufacturing practices, while green, eco-friendly processes are aligning with global sustainability standards, attracting environmentally conscious buyers.

India enjoys low operating costs, with labour costs in 2024 at just USD 1/hour versus USD 5/hour in China. The country also benefits from a large, skilled workforce, availability of locally sourced raw materials, and an improving infrastructure and logistics network. Additionally, favourable capital costs, financial incentives, and a strengthened intellectual property regime have enhanced India’s competitiveness in the sector.

India as the Next Chemical Manufacturing Hub

Historically, the EU and US dominated global chemical sales, but after the 2008 recession, the industry’s centre shifted to Asia, with China taking the lead. However, slowing Chinese growth, stricter environmental regulations, and the COVID-19 supply chain disruptions have pushed global companies towards a China+1 strategy, making India a preferred alternative.

The US–China trade war further accelerated this shift, with India benefiting from its cost advantages, supportive policies including 100% FDI in chemicals, and strong manufacturing capabilities. Over the past five years, India’s chemical industry has grown at an average 15% annually, with specialty chemicals emerging as the most lucrative segment.

India Consumer Market Overview

India is one of the fastest-growing consumer markets globally, recording a 6.5% CAGR between 2019–2025 and projected to grow at 7% till 2030. Rising disposable incomes, urbanization, increased FMCG product awareness, and evolving lifestyles are driving this expansion.

Food products dominate the consumer market with a 51% share and an expected CAGR of nearly 8% till 2030. FMCG sectors—including food, beverages, tobacco, beauty and personal care, OTC pharmaceuticals, and home care—account for around 59% of the consumer market.

The luxury goods segment is growing even faster, at a projected 10.5% CAGR between 2025–2030, reflecting rising aspirations and incomes among India’s middle class.

The FMCG industry is valued at USD 1,125 billion in 2025 and projected to grow at 7.8% CAGR till 2030, making it one of the top five GDP contributors. Urban India contributes ~55% of FMCG demand, but rural markets—currently at ~45% share—are expected to grow faster due to high penetration potential, better marketing reach, and infrastructure improvements.

Domestic Food, Beverage, and Personal Care Industries

The Indian food industry stands at USD 967 billion in 2025, growing at 9% CAGR since 2019, and is expected to maintain an 8% CAGR till 2030, when India will account for 10.5% of the global food market. Government support through initiatives like the PLI scheme and a focus on sustainable local production have made the sector highly lucrative.

The Indian beverage industry, valued at USD 105 billion in 2025, is expected to reach USD 145 billion by 2030 at 6.7% CAGR. Consumer preference for innovative, functional, and low-calorie drinks is reshaping the market.

The OTC drugs market, at USD 7.2 billion in 2025, is set to grow at 7.3% CAGR, with vitamins and minerals leading growth. Within this, the pain management market—valued at USD 530 million in 2025—is expanding at 6.8% CAGR.

The home and personal care market is valued at USD 42 billion in 2025, projected to grow at 5.9% CAGR, with beauty and personal care holding nearly 80% share by 2030. Demand for natural and premium products is driving innovation, and fragrance applications in cosmetics and home care are rising sharply.

India Flavours and Fragrances Market

The Indian flavours and fragrances market is valued at USD 2.7 billion in 2025 and is expected to reach USD 4.1 billion by 2030 at an 8.5% CAGR. Fragrances dominate with 67% share, growing at 8.9% CAGR, supported by rising disposable incomes, premiumisation, and changing consumer lifestyles.

Essential oils, expected to grow at 8.8% CAGR, are in high demand for their natural and eco-friendly appeal. India imports around USD 350 million worth of essential oils and aromatic ingredients annually, mainly from USA, Indonesia, and China.

While global giants like Givaudan, IFF, Symrise, Mane SA, and Firmenich dominate the formulated flavours and fragrances segment due to high R&D and branding barriers, Indian companies lead in aroma chemicals and essential oils, exporting about 80% of their production.

GEM Aromatics is a notable player in India, specializing in essential oil-based products derived from mint, clove, and eucalyptus oils, catering to both domestic and export markets.

BUSINESS STRENGTHS

1. Leading Position in Essential Oils and Derivatives
An established Indian manufacturer of specialty ingredients—essential oils, aroma chemicals, and value-added derivatives—with over two decades of experience. Holds a dominant market presence in essential oil-based products derived from mint, clove, eucalyptus, and other oils. In FY 2025, ranked among India’s largest procurers of piperita oil and processors of DMO, clove oil, eugenol, and eucalyptus oil, with market shares of 12% in DMO, 65% in eugenol, and over 58% in eucalyptus oil. Recognized among the largest producers of mint oil in India.

2. Diverse Portfolio and Advanced R&D
Offers 70 products across four categories: (i) mint and mint derivatives, (ii) clove and clove derivatives, (iii) phenol, and (iv) other synthetic and natural ingredients. Recently expanded into citral production, with dedicated R&D and manufacturing capabilities at the Dahej facility, including equipment for full-scale citral-based product manufacturing. Expertise spans lab trials to commercial-scale production, ensuring efficiency, quality, and cost-effectiveness.

3. Strong Customer Relationships
Supplies to leading domestic and global FMCG companies, benefiting from high entry barriers in the formulated flavours and fragrance segment due to IP protection, branding, and R&D intensity. Long-standing relationships are reinforced by the criticality of maintaining fragrance and flavour consistency, making customer replacement of suppliers rare.

4. Strategically Located, Scalable Manufacturing Facilities
Operates three manufacturing facilities in Uttar Pradesh, Dadra and Nagar Haveli and Daman and Diu, and Gujarat, with a combined installed capacity of 5,346 MTPA as of March 31, 2025, and a workforce of 177 manufacturing personnel. Facilities are designed to support diverse product manufacturing with a focus on sustainability.

5. Experienced Leadership
Guided by promoters Vipul Parekh, Kaksha Vipul Parekh, and Yash Vipul Parekh, who have expanded the company’s footprint in India and globally. Kaksha Vipul Parekh has been recognized with Export Excellence Awards (Women Entrepreneur – MSME) for 2017-18, 2018-19, and 2021-22, and the SME Activator Certificate of Felicitation from The Economic Times.

BUSINESS STRATEGIES

1. Expansion of Manufacturing Capacities
Manufacturing operations are carried out at three facilities located in Budaun (Uttar Pradesh), Silvassa (Dadra and Nagar Haveli and Daman and Diu), and Dahej (Gujarat), with plans to enhance capacities for both existing and new products.

2. Diversification of Product Portfolio
Product offerings will be broadened by expanding chemistry capabilities to increase market reach and capture greater client wallet share. Focus remains on scaling production of complex compositions, developing new products, and leveraging in-house R&D to introduce innovative solutions.

3. Sustainability and Cost Optimization
Sustainability, cost efficiency, and productivity will be improved through adoption of clean technologies and efficient operational techniques, following best industry practices across manufacturing facilities.

4. Geographical Expansion and Export Growth
With an established pan-India clientele, efforts are underway to strengthen the distribution network, expand international presence, and participate in industry-specific events globally to enhance visibility and customer engagement.

BUSINESS RISK FACTORS & CONCERNS

1. Customer Concentration Risk
A significant portion of revenue is derived from the top customer, dōTERRA Global Limited, under a supply agreement expiring December 31, 2028. Non-renewal or reduced procurement could adversely affect business performance.

2. Product Category Concentration
Revenue is heavily dependent on the mint and mint derivatives category, contributing 69.12% (FY 2025), 72.89% (FY 2024), and 69.98% (FY 2023). Any demand reduction in this segment could impact profitability.

3. Ongoing Litigation
The company is involved in litigation in the Supreme Court of India regarding the land of the Budaun Facility, contested by the State of Uttar Pradesh over alleged tax recovery issues from the previous owner. An adverse verdict may negatively affect operations and finances.

4. International Revenue Exposure
Revenue from 22 foreign countries contributed 50.66% (FY 2025), 49.56% (FY 2024), and 62.70% (FY 2023). Operations are sensitive to political, economic, and regulatory changes both in India and in export markets.

5. Supplier Dependence
Raw material supply for mint derivatives is significantly dependent on suppliers in Uttar Pradesh and Haryana, contributing a combined 42.85% (FY 2025) of total expenses. There are no long-term contracts, creating potential supply disruption risks.

6. Imported Raw Material Dependence
Imported materials, such as crude clove oil, formed 37.63% (FY 2025), 42.61% (FY 2024), and 34.12% (FY 2023) of the total raw material cost. Import restrictions or higher shipping costs could materially impact operations.

Summary:
Gem Aromatics faces concentrated customer dependence, heavy reliance on the mint derivatives category, supplier and import dependency, ongoing litigation over manufacturing land, and exposure to both domestic and international market conditions. These factors could materially impact operations, revenue, and profitability.